Press release
Chronic Obstructive Pulmonary Disease (COPD) Drug Market 2020: Global Industry Exhibits Huge Growth by Top Key Players Novartis AG, Chiesi Farmaceutici S.p.A , Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd
Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
Chronic Obstructive Pulmonary Disease (COPD) Drug Market is rising gradually to an estimated value of USD 69.29 billion by 2026 registering a steady CAGR of 4.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients, growing prevalence of chronic obstructive pulmonary disease (COPD) associated diseases and rising patient population and increase in availability of novel combination therapy drugs. A few of the major competitors currently working in the chronic obstructive pulmonary disease (COPD) drug market are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Chiesi Farmaceutici S.p.A , Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Orion Corporation, Merck & Co., Inc, Abbott, F. Hoffmann-La Roche Ltd, Vectura Group plc, Pfizer Inc, Alkermes, Mylan N.V, Almirall, S.A, Genentech, Inc, Biogen, Vectura Group plc and few among others.
Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market&pm
Market Definition: Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease which is characterized by increasing breathlessness, wheezing, and tightness in the chest. The patient of chronic obstructive pulmonary disease (COPD) experiences chronic chough, shortness of breath, fatigue, frequent flu and weight-loss. Other symptoms include emphysema, chronic bronchitis, refractory asthma and some forms of bronchiectasis.
The Global Burden of Disease Study reports a prevalence of 251.00 million cases of chronic obstructive pulmonary disease (COPD) globally in 2016. Globally, it is estimated that 3.17 million deaths were caused by the disease in 2015 (that is, 5% of all deaths globally in that year)
Market Drivers
Growing prevalence of chronic obstructive pulmonary disease (COPD) associated diseases
Rising patient population and increase in availability of novel combination therapy drugs
Increasing awareness regarding chronic obstructive pulmonary disease (COPD)
High smoking prevalence
Growing medical spending, increasing global healthcare expenditure and technological advancements in pharmaceuticals research
Market Restraints
Effective treatment is either unavailable or unaffordable
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth of the market
Lack of awareness among the patient and physician about chronic obstructive pulmonary disease (COPD) treatment
Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market&pm
Key Developments in the Market:
In April 2019, Circassia and AstraZeneca received collaborative FDA approval for Duaklir which is a fixed-dose combination of the long-acting muscarinic antagonist (LAMA) aclidinium bromide and long-acting beta-agonist (LABA) formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease (COPD), administered twice-daily via the AstraZeneca's breath-actuated inhaler Pressair
In February 2019, Mylan N.V received FDA approval for Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP) which is first generic version of Advair Diskus by GlaxoSmithKline Plc. This drug is used for the treatment of asthma or other chronic obstructive pulmonary disease (COPD). As it is a first substitutable generic of ADVAIR DISKUS it increases affordability to all healthcare system
For More Insights Get Detailed TOC @https://www.databridgemarketresearch.com/toc?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market&pm
Segmentation: Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
By Type
Chronic bronchitis
Pulmonary emphysema
Asthma
By Mechanism Type
Bronchodilators
Selective ?2-adrenergic agonists (short- and long-acting)
Theophylline
Anticholinergics
Glucocorticoids
Anti-muscarinic drugs
By Drug Type
Aclidinium
Arformoterol
Formoterol
Glycopyrrolate
Indacaterol
albuterol
Levalbuterol
Prednisolone
Fluticasone
By Therapy
Oxygen therapy
Pulmonary Rehabilitation Program
By Route of Administration
Oral
Inhaled
Intravenous
Others
By Device Type
Inhalers
Pressurized metered-dose inhalers (MDIS)
Dry-powder inhalers (DPIS)
Nebulizers
Soft mist inhalers
Others
By End User
Hospitals
Homecare
Specialty Clinics
Others
Reasons to Purchase this Report
Current and future of global chronic obstructive pulmonary disease drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Obstructive Pulmonary Disease (COPD) Drug Market 2020: Global Industry Exhibits Huge Growth by Top Key Players Novartis AG, Chiesi Farmaceutici S.p.A , Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd here
News-ID: 1964635 • Views: …
More Releases from Data Bridge Market Research
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportuni …
The trustworthy Hibiscus Flower Powder Market study details the key actions taken by the leading companies and brands, including innovations, product launches, mergers, joint ventures, acquisitions, and competitive analysis in the industry. This winning market paper can cover more ground than just market scenarios and main players' pricing comparisons. It's a comprehensive background study of the sector that also estimates the parental market. A top-notch Hibiscus Flower Powder Market research report…
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Stra …
A crucial source of information, the Caffeinated Beverage Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The…
Oral Cancer Treatment Market Size, Share, Industry Growth, Global Trends, Busine …
When it comes to developing long-term and lucrative business plans, valuable and applicable market insights are crucial. A business study on the Oral Cancer Treatment Market is very helpful when planning production, new product launches, pricing, inventories, acquisitions, and marketing tactics. Categorization by companies, region, type, and end-use industry is provided in this market analysis. This market research report holds the key to better decision-making, increased income generation, and profitable business…
Milking Systems Market Size, Share, Trends, Growth Overview by Segments, Compani …
An important Milking Systems Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Milking Systems Market study, the goals of the marketing research are taken into…
More Releases for COPD
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography ďż˝ Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858
The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market…
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would…
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the…
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the…
